Hao Sheng
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
-
- RNA modifications and cancer
- Cancer-related gene regulation
- Epigenetics and DNA Methylation
- Gut microbiota and health
- Metabolism, Diabetes, and Cancer
Papers in
-
- Renal Diseases and Glomerulopathies 6
-
- Cancer, Hypoxia, and Metabolism 4
- Cancer-related molecular mechanisms research 3
- Co-authors
- Feng ZhangSiwei WangChangliang ShanShuai ZhangYuanyuan WengYongfeng BaiXueyu FanShuangping Liu
- Journals
- Scientific Reports (3 papers)Cell Death and Disease (3 papers)Nutrition and Diabetes (2 papers)Biochemical Pharmacology (2 papers)Phytomedicine (2 papers)
- Partner nations
- ChinaUnited StatesEgypt
In The Last Decade
Hao Sheng
48 papers receiving 958 citations
Peers
Comparison fields: 5 of 106
- Cancer Research 238
- Molecular Biology 613
- Nephrology 58
- Biological Psychiatry 15
- Physiology 125
Countries citing papers authored by Hao Sheng
This map shows the geographic impact of Hao Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Sheng more than expected).
Fields of papers citing papers by Hao Sheng
This network shows the impact of papers produced by Hao Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Sheng. The network helps show where Hao Sheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Hao Sheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 0 | |
| 6 | 2022 | 13 | |
| 7 | Determination of the pathogenicity of a novel COL4A5 missense variant by CRISPR-Cas9 in kidney podocytes. | 2021 | 1 |
| 8 | 2021 | 75 | |
| 9 | 2021 | 22 | |
| 10 | 2021 | 25 | |
| 11 | 2021 | 23 | |
| 12 | 2020 | 49 | |
| 13 | 2020 | 2 | |
| 14 | 2020 | 54 | |
| 15 | 2020 | 4 | |
| 16 | Comparative study of in vitro effects of different nanoparticles at non-cytotoxic concentration on the adherens junction of human vascular endothelial cells | 2019 | 1 |
| 17 | Emerging roles of circular RNAs in colorectal cancer | 2019 | 1 |
| 18 | 2019 | 26 | |
| 19 | 2016 | 10 | |
| 20 | 2008 | 13 |
About Hao Sheng
Hao Sheng is a scholar working on Nephrology, Cancer Research, Pathology and Forensic Medicine, Complementary and Manual Therapy and Molecular Biology, having authored 52 papers that have together received 965 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (6 papers), Histone Deacetylase Inhibitors Research (5 papers), Metabolism, Diabetes, and Cancer (4 papers), Cancer Mechanisms and Therapy (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Epigenetics and DNA Methylation (4 papers), Biomedical Research and Pathophysiology (3 papers) and Cancer-related molecular mechanisms research (3 papers). The work is most often cited by research in Cancer Research (238 citations), Molecular Biology (613 citations), Nephrology (58 citations), Biological Psychiatry (15 citations) and Physiology (125 citations). Hao Sheng has collaborated with scholars based in China, United States and Egypt. Frequent co-authors include Feng Zhang, Siwei Wang, Changliang Shan, Shuai Zhang, Yuanyuan Weng, Yongfeng Bai, Xueyu Fan, Shuangping Liu, Wenjing Sun and Bin Lü. Their work appears in journals such as Scientific Reports, Cell Death and Disease, Nutrition and Diabetes, Biochemical Pharmacology and Phytomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.